<DOC>
	<DOCNO>NCT02679924</DOCNO>
	<brief_summary>Soft tissue augmentation injectable hyaluronic acid ( HA ) well-established modality correction facial volume loss , fat atrophy , fine line , wrinkle . HA glycosaminoglycan compose repeat D-glucuronic acid D-N-acetylglucosamine disaccharide unit . Because HA natural inert constituent dermis , represent ideal substance soft tissue augmentation . Current FDA-approved HA filler typically utilized either directly target specific cutaneous rhytids restore overall contour placement fat pad along bony structure remodel age . Restylane® Silk transparent injectable HA gel receive FDA approval June 2014 use lips peri-oral region . Its unique synthesis result small finer particle demonstrate significant hygroscopic property give rise potential unique application . One application concern concept `` skin boosting '' whereby microaliquots HA place skin induce biophysical improvement dermal characteristic ( 1 ) . Using technique , recent split-body study Streker et al . demonstrate significant aesthetic improvement face , hand décolletage ( 2 ) . However , well-controlled study validate aesthetic outcome utilize Restylane® Silk fashion date . Because unique combination ultra-fine product high water-attracting capability , investigator hypothesize microinjections Restylane® Silk use grid-like injection pattern rejuvenation age cheek .</brief_summary>
	<brief_title>A Slit Face Trial Using Micro-injections Transparent Hyaluronic Acid Gel Rejuvenation Cheek</brief_title>
	<detailed_description>This single center , prospective , randomize , sham-controlled , double-blind , split-face trial use micro-injections Restylane® Silk correction mid low cheek fine line wrinkle . Twenty ( 20 ) subject enrol . Each subject receive Restylane® Silk define area mid low cheek randomize blinded fashion contralateral cheek treat sham injection . The injection deliver intradermally 1mm depth via multiple 0.02 cc microinjections distribute grid array pattern 0.5 cm 1 cm injection point total treatment area . The sham injection administer identical fashion consist sterile normal saline . Following completion injection treatment , manual massage apply full area promote even distribution product . The maximum amount Restylane Silk use per treatment session/per cheek balancing treatment is1cc ( exceed total 3cc ) per treat patient . Three dimensional digital photography utilize Vectra 3D System ( Canfield ) utilize document pre-treatment status , sit injection , post-treatment effect . Subjects follow 1 week , 2 week , 4 week , day 90 , day 180 time point . At Day 180 time point , every subject give option receive touch balancing treatment cheek .</detailed_description>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Male female general good health age 18 . Mild moderate static rhytids involve least 9 cm2 area mid low cheek . Must willing give sign HIPPA form , photo consent inform consent form . Must willing comply study dose complete entire course study . Female patient either nonchildbearing potential define : 1 . Having uterus 2 . No menses least 12 month 3 . Bilateral tubal ligation Or ; ( WOCBP ) woman childbearing potential must agree use effective method birth control course study , : 1 . Oral contraceptive pill , injection , implant , patch , vaginal ring , intrauterine device 2 . Intrauterine coil 3 . Barrier method use additional form contraception ( e.g. , sponge , spermicide condom ) 4 . Abstinence ( If practice abstinence must agree use barrier method describe ( 3 ) become sexually active ) . 5 . Vasectomized partner ( must agree use barrier method describe ( 3 ) become sexually active unvasectomized ) . Negative urine pregnancy test result Baseline prior study entry ( applicable ) Pregnant , plan pregnancy course study breastfeed Severe static rhytids mid low cheek Previous use form soft tissue augmentation treatment area within past 12 month Preexisting medical dermatologic condition treatment area may affect treatment interpretation treatment effect ( investigator discretion ) Presence tattoo and/or scar treatment area investigator opinion would interfere study assessment Use oral/topical retinoids within 1 month Baseline Previous use botulinum toxin treatment area within past 6 month Previous surgical procedure treatment area within past 12 month Presence evidence condition opinion investigator might impede subject 's ability give consent comply protocol requirement . Current participation participation within 30 day prior start study drug investigational research study History noncompliance clinical research protocol Ablative laser resurface face within 12 month Nonablative laser light procedure face within past 3 month Known allergy Restylane® Silk constituent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>